Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Large-Scale European Project Initiated for Imaging in Stem Cell Therapy Research

By Biotechdaily staff writers
Posted on 24 Jun 2008
An international research group from 10 countries is planning to develop imaging technologies and methods in the field of cell therapy.

The European Institute for Biomedical Imaging Research (EIBIR; Vienna, Austria) has taken over the coordination of a European large-scale research project. More...
The project, entitled ENCITE (European Network for Cell Imaging and Tracking Expertise), began on June 1, 2008.

Currently, there is no single imaging modality that meets the requirements of stem cell therapy. However, magnetic resonance imaging (MRI) has huge potential in this regard. Moreover, other imaging methods, particularly optical imaging, will be considered in the course of the project. Within the framework of the project, new MRI imaging techniques and biomarkers will be developed and evaluated to get a more comprehensive outlook of cell fate and the reaction of the immune system. Ultimately, these are planned to be applied in the treatment of cancer, cardiovascular diseases and diabetes.

The project is supported by a financial contribution of EUR 11 million within the European Commission's seventh Framework Program. EIBIR was founded in January 2006 and is a nonprofit organization with more than 200 member institutions from 27 countries. As the project develops, further highly qualified partners will be needed to contribute either research or dissemination and training activities for the newly developed methods. In order to find these partners, a Competitive Call will be launched in the project ENCITE in autumn 2008.


Related Links:
European Institute for Biomedical Imaging Research

Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.